In casualty insurance, providing for coverage of COVID-19 vaccines.
Summary
HB1802 would amend Pennsylvania’s Insurance Company Law of 1921 to require health insurance policies offered, issued, or renewed in the Commonwealth to cover FDA-approved COVID-19 vaccines without any cost-sharing. The bill also requires state government health programs, specifically Medical Assistance and the Children’s Health Insurance Program (CHIP), to provide COVID-19 vaccine coverage without deductibles, copayments, coinsurance, or similar out-of-pocket charges.
The bill defines key terms such as “cost-sharing,” “COVID-19 vaccine,” “government program,” “health insurance policy,” and “insurer,” and it excludes a range of limited-benefit or specialized policies, including Medicare supplement, dental-only, vision-only, workers’ compensation, auto medical payment, and certain military-related coverage. It also includes a transition rule preventing existing policies that already cover COVID-19 vaccines without cost-sharing from reducing that coverage or adding cost-sharing before the new requirements take effect.
Impact
HB1802 would create a new section in the Insurance Company Law of 1921 and impose a statewide mandate on private health insurers and certain public coverage programs to pay for COVID-19 vaccines with no patient cost-sharing. It would affect insurers regulated under Pennsylvania insurance law, HMOs, hospital plan corporations, and professional health services plan corporations, while excluding several limited-benefit policy types. The bill would also directly affect Medical Assistance and CHIP by requiring those programs to cover COVID-19 vaccines without out-of-pocket charges.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as a public-health and consumer-protection bill with a straightforward coverage mandate. The sponsor list suggests support from multiple Democratic members, indicating a generally favorable posture toward maintaining vaccine access without financial barriers. No formal opposition, amendments, or recorded votes are provided in the available materials.
Contention
The main policy issue is whether insurers and public programs should be required to cover COVID-19 vaccines without any cost-sharing, which could be viewed by supporters as preserving access and by critics as a mandate that limits plan design and may increase costs. Another possible point of contention is the bill’s scope, including whether the requirement should apply broadly to all health coverage or only to certain policies, and whether the state should continue this level of vaccine coverage as federal and public-health conditions evolve. No specific objections are documented in the provided transcript or voting history.